11 insiders reported 51 Form 4 transactions for Esperion Therapeutics, Inc. (ESPR) over the past 18 months (most recent 2026-07-13). Recent activity: Hoffman Robert E. (Director) Sell 85,153 shares, CARROLL J MARTIN (Director) Sell 177,523 shares, THOMPSON JOHN CRAIG (Director) Sell 79,873 shares, Fischer Seth H. Z. (Director) Sell 141,023 shares, Shepard Jay (Director) Sell 164,472 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-13 | Hoffman Robert E. | Director | Sell | 85,153 | $0 |
| 2026-07-13 | CARROLL J MARTIN | Director | Sell | 177,523 | $0 |
| 2026-07-13 | THOMPSON JOHN CRAIG | Director | Sell | 79,873 | $0 |
| 2026-07-13 | Fischer Seth H. Z. | Director | Sell | 141,023 | $0 |
| 2026-07-13 | Shepard Jay | Director | Sell | 164,472 | $0 |
| 2026-07-13 | Koenig Sheldon L. | President and CEO | Sell | 2.1M | $0 |
| 2026-07-13 | Looker Benjamin | Chief Legal Officer | Sell | 667,524 | $0 |
| 2026-07-13 | Halladay Benjamin | Chief Financial Officer | Sell | 705,410 | $0 |
| 2026-07-13 | Harlow John B. Jr. | Chief Commercial Officer | Sell | 424,536 | $0 |
| 2026-06-18 | Koenig Sheldon L. | President and CEO | Sell | 53,588 | $169,070 |
| 2026-06-18 | Looker Benjamin | Chief Legal Officer | Sell | 11,824 | $37,305 |
| 2026-06-18 | Halladay Benjamin | Chief Financial Officer | Sell | 10,773 | $33,989 |
| 2026-06-01 | Hoffman Robert E. | Director | Buy | 79,873 | $0 |
| 2026-06-01 | CARROLL J MARTIN | Director | Buy | 79,873 | $0 |
| 2026-06-01 | THOMPSON JOHN CRAIG | Director | Buy | 79,873 | $0 |
| 2026-06-01 | Fischer Seth H. Z. | Director | Buy | 79,873 | $0 |
| 2026-06-01 | Shepard Jay | Director | Buy | 79,873 | $0 |
| 2026-03-18 | Looker Benjamin | Chief Legal Officer | Sell | 5,708 | $15,412 |
| 2026-03-18 | Halladay Benjamin | Chief Financial Officer | Sell | 6,424 | $17,409 |
| 2026-03-18 | Koenig Sheldon L. | President and CEO | Sell | 25,578 | $69,572 |
| 2026-03-16 | Koenig Sheldon L. | President and CEO | Buy | 723,760 | $0 |
| 2026-03-16 | Halladay Benjamin | Chief Financial Officer | Buy | 247,430 | $0 |
| 2026-03-16 | Looker Benjamin | Chief Legal Officer | Buy | 300,840 | $0 |
| 2026-01-21 | Looker Benjamin | General Counsel | Sell | 1,689 | $4,864 |
| 2025-12-18 | Halladay Benjamin | Chief Financial Officer | Sell | 7,337 | $26,927 |
Source: SEC Form 4 filings · as of 2026-07-13